CorCon   Report issue

For profit
Founded: Parma Italy (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
2009
NCT02529631
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

orlistat (xenical) (1 trial)

polyglucosamine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2